Literature DB >> 24049898

African swine fever convalescent sows: subsequent pregnancy and the effect of colostral antibody on challenge inoculation of their pigs.

D H Schlafer1, J W McVicar, C A Mebus.   

Abstract

The effect of African swine fever (ASF) virus infection on reproductive performance of recovered sows and their pigs was investigated. Six sows were inoculated with a 1979 ASF isolate from the Dominican Republic. One sow was bred on postinoculation day (PID) 58 and killed on PID 148. Four sows were bred between PID 368 and 419 and were allowed to farrow. One sow did not conceive. Samples collected during pregnancy, at farrowing, and during lactation were tested for virus by tissue culture and animal inoculations to determine whether ASF virus recrudesced during these natural stresses. Virus was recovered only from tissues of the sow killed on PID 148. Virus was not detected in tissue samples from the 4 other sows or from any fetus or neonate. Sow and neonatal pig sera, colostral whey, and milk whey were assayed for antibodies against ASF viral antigens, using an enzyme-linked immunosorbent assay. Antibody values in sows' sera did not change appreciably during pregnancy, farrowing, or lactation. One litter of pigs was raised with their sow. Weekly serum samples were tested for passively acquired antibodies. At 7 weeks of age, the litter was challenge inoculated with the same virus as that used initially to infect their dam. Viremia titers, duration of viremias, and clinical course were reduced. One young pig did not develop fever, viremia, clinical disease, or antibody response to virus challenge exposure. The altered course of infection was attributed to protective effect of passively acquired antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 24049898

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  15 in total

1.  ASF Exit Strategy: Providing cumulative evidence of the absence of African swine fever virus circulation in wild boar populations using standard surveillance measures.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Stahl; Antonio Velarde; Christoph Winckler; José Cortiňas Abrahantes; Sofie Dhollander; Corina Ivanciu; Alexandra Papanikolaou; Yves Van der Stede; Sandra Blome; Vittorio Guberti; Federica Loi; Simon More; Edvins Olsevskis; Hans Hermann Thulke; Arvo Viltrop
Journal:  EFSA J       Date:  2021-03-03

2.  Serum Neutralizing and Enhancing Effects on African Swine Fever Virus Infectivity in Adherent Pig PBMC.

Authors:  Jessica A Canter; Theresa Aponte; Elizabeth Ramirez-Medina; Sarah Pruitt; Douglas P Gladue; Manuel V Borca; James J Zhu
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

3.  ASF -survivors' Sera Do Not Inhibit African Swine Fever Virus Replication in Vitro.

Authors:  Marek Walczak; Małgorzata Juszkiewicz; Krzesimir Szymankiewicz; Anna Szczotka-Bochniarz; Grzegorz Woźniakowski
Journal:  J Vet Res       Date:  2022-03-25       Impact factor: 2.058

4.  Recombinant antigen targets for serodiagnosis of African swine fever.

Authors:  Carmina Gallardo; Ana Luísa Reis; Gladys Kalema-Zikusoka; Joana Malta; Alejandro Soler; Esther Blanco; R M E Parkhouse; Alexandre Leitão
Journal:  Clin Vaccine Immunol       Date:  2009-05-06

5.  Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine.

Authors:  Shehnaz Lokhandwala; Suryakant D Waghela; Jocelyn Bray; Neha Sangewar; Chloe Charendoff; Cameron L Martin; Wisam S Hassan; Tsvetoslav Koynarski; Lindsay Gabbert; Thomas G Burrage; David Brake; John Neilan; Waithaka Mwangi
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

6.  Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses.

Authors:  Jose A Barasona; Estefanía Cadenas-Fernández; Aleksandra Kosowska; Sandra Barroso-Arévalo; Belén Rivera; Rocío Sánchez; Néstor Porras; Carmina Gallardo; Jose M Sánchez-Vizcaíno
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

7.  Predicting the time to detect moderately virulent African swine fever virus in finisher swine herds using a stochastic disease transmission model.

Authors:  Sasidhar Malladi; Amos Ssematimba; Peter J Bonney; Kaitlyn M St Charles; Timothy Boyer; Timothy Goldsmith; Emily Walz; Carol J Cardona; Marie R Culhane
Journal:  BMC Vet Res       Date:  2022-03-02       Impact factor: 2.741

8.  African Swine Fever Virus CD2v Protein Induces β-Interferon Expression and Apoptosis in Swine Peripheral Blood Mononuclear Cells.

Authors:  Sabal Chaulagain; Gustavo A Delhon; Sushil Khatiwada; Daniel L Rock
Journal:  Viruses       Date:  2021-07-28       Impact factor: 5.048

9.  Thoughts on African Swine Fever Vaccines.

Authors:  Daniel L Rock
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

Review 10.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.